OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
Koen Paemeleire, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2018) Vol. 31, Iss. 3, pp. 274-280
Closed Access | Times Cited: 25
Koen Paemeleire, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2018) Vol. 31, Iss. 3, pp. 274-280
Closed Access | Times Cited: 25
Showing 25 citing articles:
Development of therapeutic antibodies for the treatment of diseases
Ruei‐Min Lu, Yu‐Chyi Hwang, I-Ju Liu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 1739
Ruei‐Min Lu, Yu‐Chyi Hwang, I-Ju Liu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 1739
The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects
Zizheng Kee, Xenia Kodji, Susan D. Brain
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 165
Zizheng Kee, Xenia Kodji, Susan D. Brain
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 165
Recent Advances in Chromatography for Pharmaceutical Analysis
Valentina D’Atri, Szabolcs Fekete, Adrian Clarke, et al.
Analytical Chemistry (2018) Vol. 91, Iss. 1, pp. 210-239
Open Access | Times Cited: 123
Valentina D’Atri, Szabolcs Fekete, Adrian Clarke, et al.
Analytical Chemistry (2018) Vol. 91, Iss. 1, pp. 210-239
Open Access | Times Cited: 123
Efficacy and Safety of Monoclonal Antibody Against Calcitonin Gene-Related Peptide or Its Receptor for Migraine: A Systematic Review and Network Meta-analysis
Xing Wang, Yuqi Chen, Jinlei Song, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Xing Wang, Yuqi Chen, Jinlei Song, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Prevalence of Migraine in the Elderly: A Narrated Review
Tissa Wijeratne, Huiliang Melissa Tang, David P. Crewther, et al.
Neuroepidemiology (2019) Vol. 52, Iss. 1-2, pp. 104-110
Closed Access | Times Cited: 53
Tissa Wijeratne, Huiliang Melissa Tang, David P. Crewther, et al.
Neuroepidemiology (2019) Vol. 52, Iss. 1-2, pp. 104-110
Closed Access | Times Cited: 53
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
Holland C. Detke, Brian A. Millen, Qi Zhang, et al.
Headache The Journal of Head and Face Pain (2019) Vol. 60, Iss. 2, pp. 348-359
Open Access | Times Cited: 49
Holland C. Detke, Brian A. Millen, Qi Zhang, et al.
Headache The Journal of Head and Face Pain (2019) Vol. 60, Iss. 2, pp. 348-359
Open Access | Times Cited: 49
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis
Xing Wang, Dingke Wen, Qiang He, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Xing Wang, Dingke Wen, Qiang He, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 23
CGRP and Brain Functioning: Cautions for Migraine Treatment
Jonathan M. Borkum
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. 8, pp. 1339-1357
Closed Access | Times Cited: 40
Jonathan M. Borkum
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. 8, pp. 1339-1357
Closed Access | Times Cited: 40
An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
Ivan Urits, Gavin Clark, Daniel An, et al.
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 195-215
Open Access | Times Cited: 28
Ivan Urits, Gavin Clark, Daniel An, et al.
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 195-215
Open Access | Times Cited: 28
Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman’s life: Implications for the efficacy and safety of novel antimigraine medications
Simone de Vries Lentsch, Eloísa Rubio‐Beltrán, Antoinette MaassenVanDenBrink
Maturitas (2021) Vol. 145, pp. 73-77
Open Access | Times Cited: 23
Simone de Vries Lentsch, Eloísa Rubio‐Beltrán, Antoinette MaassenVanDenBrink
Maturitas (2021) Vol. 145, pp. 73-77
Open Access | Times Cited: 23
Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double‐blind studies
Jessica Ailani, Eric Pearlman, Q. Zhang, et al.
European Journal of Neurology (2019) Vol. 27, Iss. 3, pp. 542-549
Open Access | Times Cited: 22
Jessica Ailani, Eric Pearlman, Q. Zhang, et al.
European Journal of Neurology (2019) Vol. 27, Iss. 3, pp. 542-549
Open Access | Times Cited: 22
Cathodal Transcranial Direct Current Stimulation of the Occipital cortex in Episodic Migraine: A Randomized Sham-Controlled Crossover Study
Rechdi Ahdab, Anthony G. Mansour, Georges Khazen, et al.
Journal of Clinical Medicine (2019) Vol. 9, Iss. 1, pp. 60-60
Open Access | Times Cited: 22
Rechdi Ahdab, Anthony G. Mansour, Georges Khazen, et al.
Journal of Clinical Medicine (2019) Vol. 9, Iss. 1, pp. 60-60
Open Access | Times Cited: 22
Preclinical studies investigating the neural mechanisms involved in the co‐morbidity of migraine and temporomandibular disorders: the role of CGRP
Simon Akerman, Marcela Romero‐Reyes
British Journal of Pharmacology (2020) Vol. 177, Iss. 24, pp. 5555-5568
Open Access | Times Cited: 19
Simon Akerman, Marcela Romero‐Reyes
British Journal of Pharmacology (2020) Vol. 177, Iss. 24, pp. 5555-5568
Open Access | Times Cited: 19
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials
Dulanji Kuruppu, James North, Amy J. Kovacik, et al.
Advances in Therapy (2021) Vol. 38, Iss. 3, pp. 1614-1626
Open Access | Times Cited: 15
Dulanji Kuruppu, James North, Amy J. Kovacik, et al.
Advances in Therapy (2021) Vol. 38, Iss. 3, pp. 1614-1626
Open Access | Times Cited: 15
Consensus of the Brazilian Headache Society (SBCe) for the Prophylactic Treatment of Episodic Migraine: part I
Eliana Meire Melhado, Paulo Sergio Faro Santos, Alexandre Ottoni Kaup, et al.
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 08, pp. 845-861
Open Access | Times Cited: 11
Eliana Meire Melhado, Paulo Sergio Faro Santos, Alexandre Ottoni Kaup, et al.
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 08, pp. 845-861
Open Access | Times Cited: 11
A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine
Nazir Noor, Alexis Angelette, Abby Lawson, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 10
Nazir Noor, Alexis Angelette, Abby Lawson, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 10
Rimegepant for the treatment of migraine
Amnon A. Berger, Ariel Winnick, Austin H. Carroll, et al.
Health psychology research (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 10
Amnon A. Berger, Ariel Winnick, Austin H. Carroll, et al.
Health psychology research (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 10
CGRP and Painful Pathologies Other than Headache
David A. Walsh, Daniel F. McWilliams
Handbook of experimental pharmacology (2019), pp. 141-167
Closed Access | Times Cited: 14
David A. Walsh, Daniel F. McWilliams
Handbook of experimental pharmacology (2019), pp. 141-167
Closed Access | Times Cited: 14
Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients
Reza Fekrazad, Ahmadreza Sardarian, Kamran Azma, et al.
Neurological Sciences (2018) Vol. 39, Iss. 7, pp. 1217-1223
Closed Access | Times Cited: 9
Reza Fekrazad, Ahmadreza Sardarian, Kamran Azma, et al.
Neurological Sciences (2018) Vol. 39, Iss. 7, pp. 1217-1223
Closed Access | Times Cited: 9
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
Janet H. Ford, Tobias Kurth, Amaal J. Starling, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 60, Iss. 10, pp. 2304-2319
Open Access | Times Cited: 9
Janet H. Ford, Tobias Kurth, Amaal J. Starling, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 60, Iss. 10, pp. 2304-2319
Open Access | Times Cited: 9
Calcitonin peptides
Dorit Naot, David S. Musson, Jillian Cornish
Elsevier eBooks (2019), pp. 789-807
Closed Access | Times Cited: 3
Dorit Naot, David S. Musson, Jillian Cornish
Elsevier eBooks (2019), pp. 789-807
Closed Access | Times Cited: 3
Problems with Developments of Breakthrough Analgesics: Recent History via Scientometric Analysis
Darin Correll, Igor Kissin
Journal of Anesthesia History (2019) Vol. 5, Iss. 2, pp. 49-57
Closed Access | Times Cited: 2
Darin Correll, Igor Kissin
Journal of Anesthesia History (2019) Vol. 5, Iss. 2, pp. 49-57
Closed Access | Times Cited: 2
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-Analysis
Xiaojing Yi, Yun Chen, Kun Chen, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Xiaojing Yi, Yun Chen, Kun Chen, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Multimodal versus monoklonal?
Astrid Gendolla
Schmerzmedizin (2018) Vol. 34, Iss. 4, pp. 21-23
Open Access
Astrid Gendolla
Schmerzmedizin (2018) Vol. 34, Iss. 4, pp. 21-23
Open Access
Migräne — Therapie im Wandel
Katharina Kamm, Andreas Straube, Lars Neeb
MMW - Fortschritte der Medizin (2019) Vol. 161, Iss. 12, pp. 50-58
Closed Access
Katharina Kamm, Andreas Straube, Lars Neeb
MMW - Fortschritte der Medizin (2019) Vol. 161, Iss. 12, pp. 50-58
Closed Access
